Xiaoguang Li

机构：Beijing University of Technology, Qilu Hospital of Shandong University · ORCID：0000-0002-2362-9130

发表论文 438 篇 · 总被引 9870 次 · h-index 47

代表论文

• Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets (2024 · MedComm · 被引 62)
• Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension (2025 · Hypertension · 被引 22)
• Dietary vitamin B3 supplementation induces the antitumor immunity against liver cancer via biased GPR109A signaling in myeloid cell (2024 · Cell Reports Medicine · 被引 18)
• Cuproptosis and Serine Metabolism Blockade Triggered by Copper‐Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy (2024 · Small · 被引 13)
• Transcriptome and metabolome analyses reveal the effects of formula and breast milk on the growth and development of human small intestinal organoids (2024 · Food Research International · 被引 11)
• Healthy lifestyles and risk of major non-communicable chronic diseases and mortality in individuals with metabolic syndrome (2025 · The journal of nutrition health & aging · 被引 7)